CH Biotech R&D Co., Ltd. Share Price

Equities

6534

TW0006534001

Agricultural Chemicals

End-of-day quote Taiwan S.E. 03:30:00 03/05/2024 am IST 5-day change 1st Jan Change
83 TWD -0.60% Intraday chart for CH Biotech R&D Co., Ltd. 0.00% +3.11%

Financials

Sales 2024 * 1.62B 50.07M 4.18B Sales 2025 * - Capitalization 8.53B 264M 22.06B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 5.28 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Second Half of 2023, Payable on April 12, 2024 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the First Half Ended June 30, 2023, Payable on October 18, 2023 CI
CH Biotech R&D Co., Ltd. Appoints Robert James Christopher Clayton as Institutional Director Representative CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CH Biotech R&D Co., Ltd. Announces Resignation of Brent Randall Smith as Natural-Person Director CI
CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Year Ended December 31, 2022, Payable on April 10, 2023 CI
CH Biotech R&D Co., Ltd.(TPEX:6534) added to S&P Global BMI Index CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day-0.60%
Current month-0.12%
1 month-2.58%
3 months+1.72%
6 months+1.22%
Current year+3.11%
More quotes
1 week
82.40
Extreme 82.4
84.30
1 month
81.70
Extreme 81.7
89.90
Current year
78.50
Extreme 78.5
95.00
1 year
71.70
Extreme 71.7
114.50
3 years
39.57
Extreme 39.5652
114.50
5 years
38.10
Extreme 38.1035
114.50
10 years
38.10
Extreme 38.1035
184.94
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01/21/01
Founder - 29/13/29
Director of Finance/CFO - 26/17/26
Members of the board TitleAgeSince
Director/Board Member - 10/15/10
Director/Board Member - 15/14/15
Founder - 29/13/29
More insiders
Date Price Change Volume
03/24/03 83 -0.60% 34,000
02/24/02 83.5 +0.48% 17,150
30/24/30 83.1 +0.73% 37,150
29/24/29 82.5 -0.60% 23,941
26/24/26 83 0.00% 64,000

End-of-day quote Taiwan S.E., May 03, 2024

More quotes
CH Biotech R&D Co Ltd, located in Taiwan, is a biotechnology company.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
83 TWD
Average target price
89 TWD
Spread / Average Target
+7.23%
Consensus

Quarterly revenue - Rate of surprise